Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 4062789, 13 pages
http://dx.doi.org/10.1155/2016/4062789
Research Article

Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria

1Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China
2Department of Rheumatology and Immunology, Drum Tower Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210008, China
3Department of Rheumatology and Immunology, The 3rd Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China

Received 24 May 2016; Revised 5 November 2016; Accepted 10 November 2016

Academic Editor: Armand Keating

Copyright © 2016 Jinyun Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Beyer Nardi and L. Da Silva Meirelles, “Mesenchymal stem cells: Isolation, in vitro expansion and characterization,” Handbook of Experimental Pharmacology, vol. 174, pp. 249–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Ryan, F. Barry, J. M. Murphy, and B. P. Mahon, “Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells,” Clinical and Experimental Immunology, vol. 149, no. 2, pp. 353–363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Xu, D. Wang, D. Liu et al., “Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome,” Blood, vol. 120, no. 15, pp. 3142–3151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Wang, J. Li, Y. Zhang et al., “Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: A Multicenter Clinical Study,” Arthritis Research and Therapy, vol. 16, article R79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Cras, D. Farge, T. Carmoi, J.-J. Lataillade, D. D. Wang, and L. Sun, “Update on mesenchymal stem cell-based therapy in lupus and scleroderma,” Arthritis Research & Therapy, vol. 17, no. 1, article 301, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Wang, X. Feng, L. Lu et al., “A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 66, no. 8, pp. 2234–2245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Feng, N. Che, Y. Liu et al., “Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 66, no. 12, pp. 3413–3423, 2014. View at Publisher · View at Google Scholar
  8. D. Wang, S. Huang, X. Yuan et al., “The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus,” Cellular & Molecular Immunology, 2015. View at Publisher · View at Google Scholar
  9. A. Bhattacharya and N. T. Eissa, “Autophagy and autoimmunity crosstalks,” Frontiers in Immunology, vol. 4, article 88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pierdominici, M. Vomero, C. Barbati et al., “Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus,” The FASEB Journal, vol. 26, no. 4, pp. 1400–1412, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Alessandri, C. Barbati, D. Vacirca et al., “T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy,” The FASEB Journal, vol. 26, no. 11, pp. 4722–4732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Gros, J. Arnold, N. Page et al., “Macroautophagy is deregulated in murine and human lupus T lymphocytes,” Autophagy, vol. 8, no. 7, pp. 1113–1123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Gergely Jr., C. Grossman, B. Niland et al., “Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 46, no. 1, pp. 175–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. J. Yang, C. E. Chee, S. Huang, and F. A. Sinicrope, “The role of autophagy in cancer: therapeutic implications,” Molecular Cancer Therapeutics, vol. 10, no. 9, pp. 1533–1541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Dhir, A. P. Singh, A. Aggarwal, S. Naik, and R. Misra, “Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study,” Lupus, vol. 18, no. 9, pp. 785–791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  17. M. Mosca and S. Bombardieri, “Assessing remission in systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 24, pp. 99–104, 2006. View at Google Scholar
  18. Z.-W. Lai, R. Borsuk, A. Shadakshari et al., “Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus,” The Journal of Immunology, vol. 191, no. 5, pp. 2236–2246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. Clarke, U. Ellinghaus, A. Cortini et al., “Autophagy is activated in systemic lupus erythematosus and required for plasmablast development,” Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 912–920, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. T. N. Caza, D. R. Fernandez, G. Talaber et al., “HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE,” Annals of the Rheumatic Diseases, vol. 73, no. 10, pp. 1888–1897, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Yu, F. Wan, S. Dutta et al., “Autophagic programmed cell death by selective catalase degradation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 4952–4957, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Espert, M. Denizot, M. Grimaldi et al., “Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4,” Journal of Clinical Investigation, vol. 116, no. 8, pp. 2161–2172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-F. Wei, M.-W. Chen, K.-C. Chen et al., “Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells,” Autophagy, vol. 10, no. 7, pp. 1179–1192, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Mariño, M. Niso-Santano, E. H. Baehrecke, and G. Kroemer, “Self-consumption: the interplay of autophagy and apoptosis,” Nature Reviews Molecular Cell Biology, vol. 15, no. 2, pp. 81–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Joshi and K. M. Ryan, “Autophagy chews fap to promote apoptosis,” Nature Cell Biology, vol. 16, no. 1, pp. 23–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Han, W. Hou, L. A. Goldstein, D. B. Stolz, S. C. Watkins, and H. Rabinowich, “A complex between Atg7 and caspase-9: a novel mechanism of cross-regulation between autophagy and apoptosis,” The Journal of Biological Chemistry, vol. 289, no. 10, pp. 6485–6497, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wang, Z. Hu, Z. Liu et al., “MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1,” Autophagy, vol. 9, no. 12, pp. 2069–2086, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. G. W. Dorn II and R. N. Kitsis, “The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble,” Circulation Research, vol. 116, no. 1, pp. 167–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Scherz-Shouval, H. Weidberg, C. Gonen, S. Wilder, Z. Elazar, and M. Oren, “p53-Dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, pp. 18511–18516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Acquistapace, T. Bru, P.-F. Lesault et al., “Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer,” STEM CELLS, vol. 29, no. 5, pp. 812–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Las and O. S. Shirihai, “Miro1: new wheels for transferring mitochondria,” The EMBO Journal, vol. 33, no. 9, pp. 939–941, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Ahmad, S. Mukherjee, B. Pattnaik et al., “Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy,” The EMBO Journal, vol. 33, no. 9, pp. 994–1010, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Wen, L. Xu, X. Chen et al., “Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/MicroRNA-155 pathway,” Journal of Immunology, vol. 190, no. 11, pp. 5411–5422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. L. H. Boudreau, A.-C. Duchez, N. Cloutier et al., “Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase a to promote inflammation,” Blood, vol. 124, no. 14, pp. 2173–2183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Marian and J. H. Anolik, “Treatment targets in systemic lupus erythematosus: biology and clinical perspective,” Arthritis Research & Therapy, vol. 14, supplement 4, article S3, 2012. View at Publisher · View at Google Scholar · View at Scopus